Discover
RLMD
Relmada Therapeutics, Inc.
6.39
2 x 4.95
2 x 8.15
bid
ask
-
0.53
7.66%
2 @ 05:24 AM
6.35 -0.04 (0.63%)
| Ytd | 32.30% | |
| 1y | 963.23% |
6.30
day range
6.97
0.55
52 week range
8.00
| Open | 6.88 | Prev Close | 6.92 | Low | 6.30 | High | 6.97 | Mkt Cap | 670.87M |
| Vol | 1.87M | Avg Vol | 1.58M | EPS | -1.09 | P/E | N/A | Forward P/E | -0.19 |
| Beta | 0.41 | Short Ratio | 4.52 | Inst. Own | 46.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 6.93 | 200-d Avg | 4.81 | 1yr Est | 0.87 |
RLMD News
benzinga.com
Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 Index
Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company"))), a clinical-s
globenewswire.com
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
CORAL GABLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Rel
benzinga.com
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call
HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highli
benzinga.com
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Analysts changed outlook on top Wall Street names. See all changes on our analyst ratings page. Chec
benzinga.com
HC Wainwright & Co. Initiates Coverage On Relmada Therapeutics with Buy Rating, Announces Price Targ
HC Wainwright & Co. analyst Andres Y. Maldonado initiates coverage on Relmada Therapeutics (N
benzinga.com
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stock
U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
Hewlett Packard Enterprise Posts Blowout Q2 Earnings, Joins Marvell Technology And Other Big Stocks
US stock futures surge on tech sector news, HPE reports strong earnings, and other tech stocks follo